BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33071214)

  • 1. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
    Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
    Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia.
    Efferth T; Gillet JP; Sauerbrey A; Zintl F; Bertholet V; de Longueville F; Remacle J; Steinbach D
    Mol Cancer Ther; 2006 Aug; 5(8):1986-94. PubMed ID: 16928819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
    Abedi M; Rahgozar S; Esmaeili A
    Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
    Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
    Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate.
    Miyachi H; Takemura Y; Kobayashi H; Ando Y
    Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines.
    Efferth T; Verdorfer I; Miyachi H; Sauerbrey A; Drexler HG; Chitambar CR; Haber M; Gebhart E
    Blood Cells Mol Dis; 2002; 29(1):1-13. PubMed ID: 12482398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.
    Catts VS; Farnsworth ML; Haber M; Norris MD; Lutze-Mann LH; Lock RB
    Leukemia; 2001 Jun; 15(6):929-35. PubMed ID: 11417479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and induction by dexamethasone of ABC transporters and nuclear receptors in a human T-lymphocyte cell line.
    Manceau S; Giraud C; Declèves X; Batteux F; Chéreau C; Chouzenoux S; Scherrmann JM; Weill B; Perrot JY; Tréluyer JM
    J Chemother; 2012 Feb; 24(1):48-55. PubMed ID: 22546724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
    Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
    Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
    Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells.
    Rahimi Babasheikhali S; Rahgozar S; Mohammadi M
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):1987-1998. PubMed ID: 31214760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug Transporters.
    Hu YH; Zhou L; Wang SS; Jing X; Guo HL; Sun F; Zhang Y; Chen F; Xu J; Ji X
    Curr Pharm Des; 2019; 25(6):627-634. PubMed ID: 30931851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
    Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
    Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSH2D contributes to methotrexate resistance in human T‑cell acute lymphoblastic leukaemia.
    Wang J; Xiong Y
    Oncol Rep; 2020 Nov; 44(5):2121-2129. PubMed ID: 33000278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of P-glycoprotein expression and function in childhood acute leukemia: a children's cancer group study.
    Ivy SP; Olshefski RS; Taylor BJ; Patel KM; Reaman GH
    Blood; 1996 Jul; 88(1):309-18. PubMed ID: 8704189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.
    Ooko E; Alsalim T; Saeed B; Saeed MEM; Kadioglu O; Abbo HS; Titinchi SJJ; Efferth T
    Toxicol Appl Pharmacol; 2016 Aug; 305():216-233. PubMed ID: 27318188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.